Eli Lilly (LLY) has acquired 4E Therapeutics, a neuroscience firm creating chronic pain treatments, 4E Therapeutics said Tuesday.
The company said its lead compound, 4ET1103, showed a favorable safety profile in a phase 1 study.
Financial terms were not disclosed.
Price: $1124.39, Change: $-4.96, Percent Change: -0.44%
Adaptive Biotechnologies (ADPT) is evaluating strategic and structural alternatives for its immune medicine segment in a plan to separate the business from its minimal residual disease division.A decision on the separation is expected by year-end, the company said Monday in a statement.Adaptive shares fell 5.6% in after-hours trading.
High Tide (HITI) reported fiscal Q2 adjusted earnings late Monday of 0.01 Canadian dollars per diluted share, compared with the loss of C$0.04 a year earlier.Three analysts surveyed by FactSet expected a loss of C$0.02.Revenue in the three months ended April 30 rose to C$179.3 million from C$137.8 million a year ago.Analysts surveyed by FactSet expected C$171.2 million.High Tide shares rose 15% in after-hours trading.
Dave & Buster's Entertainment (PLAY) reported fiscal Q1 non-GAAP net income late Monday of $0.22 per diluted share, down from $0.76 a year earlier.Analysts polled by FactSet expected $0.56.Revenue for the quarter ended May 5 was $559.2 million, down from $567.7 million a year earlier.Analysts expected $580.6 million.Shares of the company were down about 4% in after-hours trading.